2276. Immunogenicity of Takeda’s Bivalent Virus-Like Particle (VLP) Norovirus Vaccine (NoV) Candidate in Children From 6 Months up to 4 Years of Age

BACKGROUND: With the introduction of routine childhood rotavirus vaccination, norovirus is now becoming the major cause of medically-attended gastroenteritis in children. Takeda is developing a norovirus vaccine (NoV) that contains genotypes GI.1 and GII.4 consensus (GII.4c) sequence VLPs. We report...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Taisei, Lefevre, Inge, Mendelman, Paul, Sherwood, Jim, Bizjajeva, Svetlana, Borkowski, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255068/
http://dx.doi.org/10.1093/ofid/ofy210.1929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255068/
http://dx.doi.org/10.1093/ofid/ofy210.1929

Ejemplares similares